The PITU has received U.S. Food and Drug Administration Emergency Use Authorization for use on COVID-19 patients. In both the analyses of the U.S. Patent application and the FDA's EUA, "PITU was found to have no equal in the market place in addressing the needs to both isolate the patients and allow access to them."

​

​

​

​

​